Norbert Knebel

Title: Norbert Knebel: Innovator in Hormone Dependent Tumor Treatment

Introduction

Norbert Knebel is a notable inventor based in Ingolstadt, Germany. He has made significant contributions to the field of medical chemistry, particularly in the treatment of hormone dependent tumors. With a total of 2 patents to his name, his work has the potential to impact cancer treatment significantly.

Latest Patents

Knebel's latest patents include a method of treating hormone dependent tumors with diamine-platinum (II). This compound is characterized by a complex formula that includes various functional groups, making it useful for targeting specific tumor types. Another patent involves diamine-platinum (II) complex compounds, which also serve a similar purpose in treating hormone dependent tumors. Both patents highlight his innovative approach to cancer therapy.

Career Highlights

Throughout his career, Norbert Knebel has worked with reputable companies such as Asta Pharma and Asta Pharma Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.

Collaborations

Knebel has collaborated with esteemed colleagues, including Erwin Von Angerer and Helmut Schonenberger. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Norbert Knebel's contributions to the field of medical chemistry, particularly in the treatment of hormone dependent tumors, showcase his dedication to innovation. His patents reflect a commitment to improving cancer therapies, making him a significant figure in the realm of medical inventions.